OBJECTIVES: The balance between survival and death is a key point for regulation of physiology of stem cells. Recently, applications of natural products to enhance efficiencies in culturing and differentiation of stem cells are increasing. Korean mistletoe lectin (Viscum album L. var. coloratum agglutinin, VCA) has been known to be toxic to some cancer cells, but it is still unclear whether VCA has a cytotoxic or indeed a proliferative effect on mesenchymal stem cells (MSCs). Here, we have compared effects of VCA in naïve placenta-derived stem cells (PDSCs), immortalized PDSCs and cancer cells (HepG2), and analysed their mechanisms. MATERIALS AND METHODS: MTT assay was performed to analyse effects of VCA on naïve PDSCs, immortalized PDSCs and HepG2. FACS, ROS, caspase-3 assay, western blotting and immunofluorescence were performed to detect signalling events involved in self-renewal of the above cell types. RESULTS: VCA had cancer cell-specific toxicity to HepG2 cells even with low concentrations of VCA (1-5 pg/ml), toxicity was observed to immortalized PDSCs and HepG2s, while proliferation of naïve PDSCs was significantly increased (P < 0.05). ROS production by VCA treatment in naïve PDSCs was significantly lower compared to controls (P < 0.05). Furthermore, autophagy was activated in naïve PDSCs treated with VCA through increase in type II LC3 and decrease in phosphorylated mTOR. CONCLUSIONS: VCA can promote MSC proliferation through an activated autophagic mechanism.
OBJECTIVES: The balance between survival and death is a key point for regulation of physiology of stem cells. Recently, applications of natural products to enhance efficiencies in culturing and differentiation of stem cells are increasing. Korean mistletoe lectin (Viscum album L. var. coloratum agglutinin, VCA) has been known to be toxic to some cancer cells, but it is still unclear whether VCA has a cytotoxic or indeed a proliferative effect on mesenchymal stem cells (MSCs). Here, we have compared effects of VCA in naïve placenta-derived stem cells (PDSCs), immortalized PDSCs and cancer cells (HepG2), and analysed their mechanisms. MATERIALS AND METHODS:MTT assay was performed to analyse effects of VCA on naïve PDSCs, immortalized PDSCs and HepG2. FACS, ROS, caspase-3 assay, western blotting and immunofluorescence were performed to detect signalling events involved in self-renewal of the above cell types. RESULTS:VCA had cancer cell-specific toxicity to HepG2 cells even with low concentrations of VCA (1-5 pg/ml), toxicity was observed to immortalized PDSCs and HepG2s, while proliferation of naïve PDSCs was significantly increased (P < 0.05). ROS production by VCA treatment in naïve PDSCs was significantly lower compared to controls (P < 0.05). Furthermore, autophagy was activated in naïve PDSCs treated with VCA through increase in type II LC3 and decrease in phosphorylated mTOR. CONCLUSIONS:VCA can promote MSC proliferation through an activated autophagic mechanism.
Authors: Jakob Reiser; Xian-Yang Zhang; Charles S Hemenway; Debasis Mondal; Leena Pradhan; Vincent F La Russa Journal: Expert Opin Biol Ther Date: 2005-12 Impact factor: 4.388
Authors: Jin Hwa Jang; Jin Sun Jung; Young Bin Im; Kyung Sun Kang; Jee In Choi; Soo Kyung Kang Journal: Antioxid Redox Signal Date: 2011-09-21 Impact factor: 8.401
Authors: David A Castilla-Casadiego; Ana M Reyes-Ramos; Maribella Domenech; Jorge Almodovar Journal: Ann Biomed Eng Date: 2019-11-08 Impact factor: 3.934
Authors: Kam Lok Wong; Ricky Ngok Shun Wong; Liang Zhang; Wing Keung Liu; Tzi Bun Ng; Pang Chui Shaw; Philip Chi Lip Kwok; Yau Ming Lai; Zhang Jin Zhang; Yanbo Zhang; Yao Tong; Ho-Pan Cheung; Jia Lu; Stephen Cho Wing Sze Journal: Chin Med Date: 2014-07-19 Impact factor: 5.455
Authors: M Twardziok; D Meierhofer; S Börno; B Timmermann; S Jäger; Sengül Boral; A Eggert; C I Delebinski; G Seifert Journal: BMC Complement Altern Med Date: 2017-04-28 Impact factor: 3.659